Company intelligence / Profile preview
Protechsure Scientific
Aurora, Colorado, United Statesprotechsure.com ↗
- Ownership
- Private
- Employees
- ~21
- Development stage
- Other
01
Overview
Protechsure Scientific developed Difinsa53™, a silibin-based topical cream intended to prevent or treat radiation dermatitis in breast cancer patients. The main clinical trial for this indication was terminated at Phase 1/2. The company markets medical products aimed at preventing and treating skin disorders, with a focus on improving quality of life during cancer therapy and other conditions affecting the skin.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Small moleculeTopical cream
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Protechsure Scientific.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Protechsure Scientific.